Blinatumomab for CNI-Resistant/Intolerant SRNS in Children — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Blinatumomab for CNI-Resistant/Intolerant SRNS in Children — Stella

Recruiting

Back to CNI-resistant Steriod Resistant Nephrotic Syndrome trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

China

Children's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang

Key details

Phase

Early testing

Sponsor

The Children's Hospital of Zhejiang University School of Medicine

Enrollment target

~6 participants

Started

September 2024

Primary completion

September 2026

Age range

2 Years – 17 Years

Last updated August 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov